Evaluation of the Effect of Subcutaneous Heparin Injection on Pain Intensity and Bruising Incidence

Phase 1

Completed

• Conditions: Treatment: protocol designed to evaluate one or more interventions for treating a disease, syndrome or condition; Heparin Sodium

• Registration Number: TCTR20160221001
• Lead Sponsor: Mashhad university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-02-21
• Study Completion: 2016-05-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 86

Inclusion Criteria

The study population consist of all patients, admit to the Cardiology Department of Ghaem Hospital, who receive subcutaneous heparin injection. The sample size was calculated as eighty six
The patients who met the following criteria will include in the study: 1) subcutaneous heparin prescription (5,000 units per 1 mL, every 12 h ) by a physician, 2) full consciousness

Exclusion Criteria

pain and disease (such as blood coagulation, hepatic impairment, renal failure, nervous and sensory impairment in the injection site, spinal injury, diabetes, and vascular disorders, smoking or drug abuse, use of warfarin or phenobarbital, pain-relief interventions or use of analgesic medicines, redness, swelling, and bruising at the injection site, willingness to participate in the study. interventional study or registry) during the last 3 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Readmission to the hospital one year number

Secondary Outcome Measures

Name	Time	Method
incidence of bruising one year number